Full-Spectrum Blog Contact Info CRISPR/Cas9 Programs & Pipeline Patients & Families Healthcare Professionals Leadership Overview Leadership Partners Management Team Our leaders bring all the necessary skills and experience from world-leading organizations, and embody Intellia’s values – one, explore, disrupt, deliver – to deliver genome editing therapeutics. Our team comprises experts in all aspects of developing human therapeutics, including preclinical research, manufacturing and clinical development. John Leonard, M.D. President and Chief Executive Officer James Basta, J.D. Executive Vice President, General Counsel and Corporate Secretary Eliana Clark, Ph.D. Senior Vice President, Technical Operations Christine Foster, D. Phil. Senior Vice President, Business Development and Alliance Management Glenn Goddard Executive Vice President, Chief Financial Officer Ian Karp Senior Vice President, Investor Relations and Corporate Communications David Lebwohl, M.D. Executive Vice President, Chief Medical Officer Birgit Schultes, Ph.D. Senior Vice President, Head of Cell Therapies Laura Sepp-Lorenzino, Ph.D. Executive Vice President, Chief Scientific Officer Marika St. Amand Senior Vice President, Chief Human Resources Officer Board of Directors Industry veterans and experienced investors with demonstrated skills in building leading biotechnology companies. Frank Verwiel, M.D. Chairman of the Board Fred Cohen, M.D., D.Phil, F.A.C.P. Independent Director John F. Crowley Independent Director Caroline Dorsa Independent Director Jean-François Formela, M.D. Independent Director Jesse Goodman, M.D. Independent Director Georgia Keresty, Ph.D., M.P.H. Independent Director John Leonard, M.D. President and CEO, Intellia Info Overview Leadership Partners Healthcare Professionals Overview CRISPR/Cas9 What’s CRISPR/Cas9? How CRISPR/Cas9 Works Types of Edits Glossary Investors & Media Overview Press Releases Corporate Deck Events & Presentations Press Kit Corporate Governance Financial Info Stock Info Analyst Coverage Investor Resources Programs & Pipeline Intellia’s Full-Spectrum Approach Pipeline In Vivo Therapies Ex Vivo Therapies Careers Life @ Intellia Join Us Patients & Families Our Commitment Clinical Trials Community Perspectives & Resources Expanded Access Policy © Intellia Therapeutics, Inc. 2021 Cookie Policy Terms of Use Privacy Policy Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.